| pubmed-article:15065087 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:15065087 | lifeskim:mentions | umls-concept:C0376358 | lld:lifeskim |
| pubmed-article:15065087 | lifeskim:mentions | umls-concept:C0004083 | lld:lifeskim |
| pubmed-article:15065087 | lifeskim:mentions | umls-concept:C0427716 | lld:lifeskim |
| pubmed-article:15065087 | lifeskim:mentions | umls-concept:C1442972 | lld:lifeskim |
| pubmed-article:15065087 | lifeskim:mentions | umls-concept:C0332282 | lld:lifeskim |
| pubmed-article:15065087 | lifeskim:mentions | umls-concept:C1304757 | lld:lifeskim |
| pubmed-article:15065087 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:15065087 | pubmed:dateCreated | 2004-4-5 | lld:pubmed |
| pubmed-article:15065087 | pubmed:abstractText | We evaluated the association of pre-diagnostic plasma concentration of C-reactive protein, a sensitive, but non-specific indicator of inflammation, with subsequent risk of prostate cancer. | lld:pubmed |
| pubmed-article:15065087 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15065087 | pubmed:language | eng | lld:pubmed |
| pubmed-article:15065087 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15065087 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:15065087 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15065087 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:15065087 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:15065087 | pubmed:issn | 0270-4137 | lld:pubmed |
| pubmed-article:15065087 | pubmed:author | pubmed-author:HelzlsouerKat... | lld:pubmed |
| pubmed-article:15065087 | pubmed:author | pubmed-author:RifaiNaderN | lld:pubmed |
| pubmed-article:15065087 | pubmed:author | pubmed-author:PlatzElizabet... | lld:pubmed |
| pubmed-article:15065087 | pubmed:author | pubmed-author:De... | lld:pubmed |
| pubmed-article:15065087 | pubmed:author | pubmed-author:HoffmanSandra... | lld:pubmed |
| pubmed-article:15065087 | pubmed:author | pubmed-author:ErlingerThoma... | lld:pubmed |
| pubmed-article:15065087 | pubmed:author | pubmed-author:VisvanathanKa... | lld:pubmed |
| pubmed-article:15065087 | pubmed:copyrightInfo | Copyright 2004 Wiley-Liss, Inc. | lld:pubmed |
| pubmed-article:15065087 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:15065087 | pubmed:day | 1 | lld:pubmed |
| pubmed-article:15065087 | pubmed:volume | 59 | lld:pubmed |
| pubmed-article:15065087 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:15065087 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:15065087 | pubmed:pagination | 393-400 | lld:pubmed |
| pubmed-article:15065087 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
| pubmed-article:15065087 | pubmed:meshHeading | pubmed-meshheading:15065087... | lld:pubmed |
| pubmed-article:15065087 | pubmed:meshHeading | pubmed-meshheading:15065087... | lld:pubmed |
| pubmed-article:15065087 | pubmed:meshHeading | pubmed-meshheading:15065087... | lld:pubmed |
| pubmed-article:15065087 | pubmed:meshHeading | pubmed-meshheading:15065087... | lld:pubmed |
| pubmed-article:15065087 | pubmed:meshHeading | pubmed-meshheading:15065087... | lld:pubmed |
| pubmed-article:15065087 | pubmed:meshHeading | pubmed-meshheading:15065087... | lld:pubmed |
| pubmed-article:15065087 | pubmed:meshHeading | pubmed-meshheading:15065087... | lld:pubmed |
| pubmed-article:15065087 | pubmed:meshHeading | pubmed-meshheading:15065087... | lld:pubmed |
| pubmed-article:15065087 | pubmed:meshHeading | pubmed-meshheading:15065087... | lld:pubmed |
| pubmed-article:15065087 | pubmed:meshHeading | pubmed-meshheading:15065087... | lld:pubmed |
| pubmed-article:15065087 | pubmed:meshHeading | pubmed-meshheading:15065087... | lld:pubmed |
| pubmed-article:15065087 | pubmed:meshHeading | pubmed-meshheading:15065087... | lld:pubmed |
| pubmed-article:15065087 | pubmed:year | 2004 | lld:pubmed |
| pubmed-article:15065087 | pubmed:articleTitle | No association between pre-diagnostic plasma C-reactive protein concentration and subsequent prostate cancer. | lld:pubmed |
| pubmed-article:15065087 | pubmed:affiliation | Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA. eplatz@jhsph.edu | lld:pubmed |
| pubmed-article:15065087 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:15065087 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15065087 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15065087 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15065087 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15065087 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15065087 | lld:pubmed |
